Aytu Biopharma (AYTU) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Aytu Biopharma (AYTU) over the last 17 years, with Q4 2025 value amounting to 0.12.
- Aytu Biopharma's Equity Ratio fell 5602.47% to 0.12 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.12, marking a year-over-year decrease of 5602.47%. This contributed to the annual value of 0.15 for FY2025, which is 3492.18% down from last year.
- Per Aytu Biopharma's latest filing, its Equity Ratio stood at 0.12 for Q4 2025, which was down 5602.47% from 0.19 recorded in Q3 2025.
- In the past 5 years, Aytu Biopharma's Equity Ratio ranged from a high of 0.53 in Q1 2021 and a low of 0.12 during Q4 2025
- In the last 5 years, Aytu Biopharma's Equity Ratio had a median value of 0.28 in 2023 and averaged 0.31.
- Examining YoY changes over the last 5 years, Aytu Biopharma's Equity Ratio showed a top increase of 1764.61% in 2025 and a maximum decrease of 5602.47% in 2025.
- Aytu Biopharma's Equity Ratio (Quarter) stood at 0.47 in 2021, then tumbled by 31.3% to 0.32 in 2022, then dropped by 22.73% to 0.25 in 2023, then increased by 5.75% to 0.26 in 2024, then crashed by 56.02% to 0.12 in 2025.
- Its last three reported values are 0.12 in Q4 2025, 0.19 for Q3 2025, and 0.15 during Q2 2025.